BridgeBio Oncology Therapeutics, Inc.
BBOT
$9.71
$0.879.84%
NASDAQ
| 06/30/2025 | 03/31/2025 | 06/30/2024 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 131.40M | 135.72M | -- | ||
| Total Receivables | 1.08M | 40.00K | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | 4.30M | 2.67M | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | 5.58M | 2.90M | -- | ||
| Total Current Assets | 142.35M | 141.33M | -- | ||
|
|
|||||
| Total Current Assets | 142.35M | 141.33M | -- | ||
| Net Property, Plant & Equipment | 3.45M | 3.36M | -- | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | 5.46M | 5.15M | -- | ||
| Total Assets | 151.25M | 149.84M | -- | ||
|
|
|||||
| Total Accounts Payable | 2.20M | 3.65M | -- | ||
| Total Accrued Expenses | 24.40M | 16.08M | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | 320.00K | 6.00K | -- | ||
| Total Finance Division Other Current Liabilities | 330.00K | 4.32M | -- | ||
| Total Other Current Liabilities | 330.00K | 4.32M | -- | ||
| Total Current Liabilities | 27.25M | 24.06M | -- | ||
|
|
|||||
| Total Current Liabilities | 27.25M | 24.06M | -- | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | 2.51M | 2.64M | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | -- | -- | -- | ||
| Total Liabilities | 29.77M | 26.70M | -- | ||
|
|
|||||
| Common Stock & APIC | 45.23M | 44.35M | -- | ||
| Retained Earnings | -273.01M | -244.58M | -- | ||
| Treasury Stock & Other | 51.00K | 191.00K | -- | ||
| Total Common Equity | -227.73M | -200.03M | -- | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | 349.22M | 323.17M | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | 349.22M | 323.17M | -- | ||
|
|
|||||
| Total Common Equity | -227.73M | -200.03M | -- | ||
| Total Preferred Equity | 349.22M | 323.17M | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | 121.49M | 123.14M | -- | ||
|
|
|||||